Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Zemánková · SciRah

Researcher profile · Semantic Scholar

A. Zemánková

Share profile

A. Zemánková — researcher profile on SciRah

h-index: 7
Works: 34
Citations: 127

Most-cited papers

First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.
T. El Zarif, K. Semaan, Wan-Ling Xie, M. Eid +34 more
2024European Urology29 citations
Semantic Scholar
Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature
H. Študentová, Jindřiška Voláková, M. Spisarová, A. Zemánková +3 more
2022BMC Gastroenterology20 citations Open access
Semantic Scholar
The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
H. Študentová, M. Spisarová, Andrea Kopová, A. Zemánková +2 more
2023Cancers15 citations Open access
Semantic Scholar
The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature
H. Študentová, N. Rušarová, Andrea Ondrušková, A. Zemánková +3 more
2022Current Oncology12 citations Open access
Semantic Scholar
Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib
T. Buchler, M. Kopecká, A. Zemánková, M. Wiesnerová +5 more
2020Targeted oncology10 citations
Semantic Scholar
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
A. Poprach, I. Kišš, M. Staník, Tamara Barusová +12 more
2023Targeted oncology7 citations
Semantic Scholar
A Pathological Complete Response to the Combination of Ipilimumab and Nivolumab in a Patient with Metastatic Renal Cell Carcinoma
H. Študentová, A. Zemánková, M. Spisarová, Daniela Škanderová +3 more
2022Medicina7 citations Open access
Semantic Scholar
Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers.
I. Richter, A. Poprach, A. Zemánková, T. Buchler +7 more
2020Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia6 citations Open access
Semantic Scholar
Biomarkers of Inflammation and Progression During Immunotherapy in Patients With Metastatic Renal Cell Carcinoma
M. Spisarová, B. Melichar, Jarmila Juráňová, A. Zemánková +6 more
2023In Vivo5 citations Open access
Semantic Scholar
The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab
O. Fiala, Michaela Tkadlecová, J. Kopecký, Petr Hosek +15 more
2026In Vivo3 citations Open access
Semantic Scholar
Neoadjuvant nivolumab and cabozantinib in advanced renal cell carcinoma in a horseshoe kidney – how to achieve a safe and radical resection? a case report and review of the literature
A. Zemánková, H. Študentová, Andrea Kopová, T. Tichý +2 more
2023Frontiers in Oncology3 citations Open access
Semantic Scholar
Changes in expression of lysosomal membrane proteins in leucocytes of cancer patients treated with tyrosine kinase inhibitors
N. Pastvova, J. Havlásek, P. Doležel, K. Kikalová +4 more
2021Cancer Chemotherapy and Pharmacology3 citations
Semantic Scholar
First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma (RCC): An international multi-center study.
T. El Zarif, K. Semaan, Wan-Ling Xie, C. Nguyen +16 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Nivolumab in previously treated metastatic renal cell carcinoma: real-world data from the Czech Republic and Slovakia
O. Fiala, Michaela Tkadlecová, T. Buchler, J. Kopecký +18 more
2026Frontiers in Immunology1 citations Open access
Semantic Scholar
Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab
O. Fiala, Petr Hosek, Michaela Tkadlecová, B. Melichar +15 more
2025Clinical and Experimental Metastasis1 citations Open access
Semantic Scholar
Baseline and early changes in eosinophil count and neutrophil-to-eosinophil ratio predict outcomes in metastatic renal cell carcinoma treated with nivolumab
O. Fiala, K. Rejlekova, T. Buchler, H. Študentová +19 more
2025Scientific Reports1 citations Open access
Semantic Scholar
Avelumab first-line maintenance (1LM) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Czech Republic: Interim real-world results from a national reimbursement registry.
A. Zemánková, H. Študentová, B. Melichar, Michal Eid +13 more
2024Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Cabozantinib in the treatment of metastatic renal cell carcinoma - final data analysis from four oncology centers in the Czech Republic.
Igor Richter, A. Poprach, A. Zemánková, T. Büchler +7 more
2021Klinicka onkologie1 citations Open access
Semantic Scholar
Combination of systemic and surgical treatment in a patient with primarily inoperable renal cell carcinoma in a horseshoe kidney: the importance of multidisciplinary collaboration - updated results of 3-year follow-up
J. Heřman, Vladimír Študent, A. Vidlář, A. Zemánková +1 more
2026Czech Urology0 citations Open access
Semantic Scholar
Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinoma
O. Fiala, J. Králíček, J. Kopecký, M. Vočka +17 more
2026Frontiers in Immunology0 citations Open access
Semantic Scholar
Early systemic inflammatory–metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumab
O. Fiala, T. Buchler, A. Poprach, J. Kopecký +18 more
2026Scientific Reports0 citations Open access
Semantic Scholar
Translating avelumab maintenance into clinical practice: nationwide outcomes in Czech patients with advanced or metastatic urothelial carcinoma.
A. Zemánková, B. Melichar, Michal Eid, A. Poprach +15 more
2026Future Oncology0 citations Open access
Semantic Scholar
Undertreatment of metastatic urothelial carcinoma: A Czech real-world data analysis
H. Študentová, K. Hola, J. Habetinek, M. Spisarová +5 more
2025European Urology Open Science0 citations Open access
Semantic Scholar
P1.11.10 Serum Neopterin and Mortality in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
M. Spisarová, A. Zemánková, H. Študentová, V. Kučerová +2 more
2025Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Cardiac dysfunction in patients with kidney cancer receiving immunotherapy
M. Spisarová, J. Vymětal, H. Študentová, B. Melichar +2 more
2025European Heart Journal, Supplement0 citations
Semantic Scholar
Second-line cabozantinib after failure of immune-based therapy in patients with metastatic renal cell carcinoma: Analysis of the RENIS II registry
H. Študentová, K. Kopeckova, A. Zemánková, M. Spisarová +10 more
2025European Urology Open Science0 citations Open access
Semantic Scholar
Avelumab first-line (1L) maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Czech Republic: Updated real-world results from a national reimbursement registry.
H. Študentová, A. Zemánková, B. Melichar, Michal Eid +15 more
2025Journal of Clinical Oncology0 citations
Semantic Scholar
Serum neopterin and overall survival in patients with metastatic renal cell carcinoma
A. Zemánková, M. Spisarová, K. Hola, M. Marhefka +8 more
2025European Urology Open Science0 citations Open access
Semantic Scholar
2326P Systemic therapy of muscle-invasive urothelial cancer in the Czech Republic: The value of the MDT approach and referral to comprehensive oncology centres
H. Študentová, K. Hola, J. Habetinek, M. Spisarová +6 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
Enfortumab vedotin in the treatment of urothelial bladder carcinoma
Kateřina Pejřová, A. Zemánková
2024Onkologie0 citations
Semantic Scholar
Clear-cell renal cell carcinoma with sarcomatoid dedifferentiation treated with immunotherapy
Andrea Ondrušková, H. Študentová, A. Zemánková
2023Onkologie0 citations
Semantic Scholar
Correction to: Changes in expression of lysosomal membrane proteins in leucocytes of cancer patients treated with tyrosine kinase inhibitors
N. Pastvova, J. Havlásek, P. Doležel, K. Kikalová +4 more
2021Cancer Chemotherapy and Pharmacology0 citations Open access
Semantic Scholar
Komplikace a rizika laserové refrakční chirurgie
A. Zemánková
20140 citations
Semantic Scholar
Isolation of P-glycoprotein inhibitors from Schisandrachinensis
Jiří Slanina, Martina Čarnecká, A. Zemánková, O. Peš +3 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Študentová×27
Invite
H. Študentová — researcher profile on SciRah
M. Spisarová×16
Invite
M. Spisarová — researcher profile on SciRah
A. Poprach×13
Invite
A. Poprach — researcher profile on SciRah
B. Melichar×12
Invite
B. Melichar — researcher profile on SciRah

×11

Invite

B. Melichar — researcher profile on SciRah

Invite

J. Kopecký — researcher profile on SciRah

Invite

O. Fiala — researcher profile on SciRah

Michaela Tkadlecová×6

Invite

Michaela Tkadlecová — researcher profile on SciRah

Invite

M. Vočka — researcher profile on SciRah

Martin Matějů×6

Invite

Martin Matějů — researcher profile on SciRah

Radka Lohynská×6

Invite

Radka Lohynská — researcher profile on SciRah

Petr Stránský×6

Invite

Petr Stránský — researcher profile on SciRah